Stanford researchers are using patients’ own skin cells to correct a rare, debilitating skin disorder.
News that a woman has given birth via an ovary frozen when she was nine years old is just one example of how technology is altering the limits of fertility.
The British government has given the green light for a technique that will let parents-to-be sidestep mitochondrial disease.
Why does a mole rat live 30 years but a mouse only three? With $1.5 billion in the bank, Google’s anti-aging spinout Calico is rich enough to find out.
The legal battle over who invented the powerful gene-editing tool isn’t likely to dim hopes for better crops and powerful new medical treatments.
Finding telltale mutations in tumors and targeting those cancers with precisely selected drugs is the newest front in the war on cancer. Now researchers just have to figure out why it doesn’t work for everyone.
An audacious startup thinks it can give 40-ish women a better shot at having children. Should desperate would-be parents believe it?
A majority of patients in a small clinical trial have been in remission from a deadly type of cancer for more than four years.
Attorneys in a dispute over CRISPR gene-editing make their case to patent judges.
People voice concerns about drugs via search queries—and that data that can predict when one might be recalled.